1
|
Wang Y, Li Q, Song X, Wang J, Yin X, Li SS, Wang L. Chemoselective and diastereoselective construction of 4-alkylidene-tetrahydroquinoline via a redox-neutral vinylogous cascade [1,7]-hydride transfer/6- endo-trig cyclization strategy. Org Biomol Chem 2023; 21:4007-4012. [PMID: 37128724 DOI: 10.1039/d3ob00223c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Herein, we disclose a chemoselective and diastereoselective synthesis of the medicinally significant 4-alkylidene-tetrahydroquinoline via a redox-neutral vinylogous cascade condensation/[1,7]-hydride transfer/6-endo-trig cyclization strategy, which features a novel product skeleton, high chemoselectivity and diastereoselectivity, facile introduction of 4-alkylidenyl motifs, employment of α,β,γ,δ-unsaturated dicyanoalkenes as novel hydride acceptors, and green and metal-free conditions with water as the only by-product. Additionally, the versatility of α,α-dicyanoalkenes has been fully exploited as hydride acceptors and γ-exclusive nucleophiles consecutively for accessing novel heterocyclic skeletons.
Collapse
Affiliation(s)
- Yufeng Wang
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| | - Qiang Li
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| | - Xiaopei Song
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| | - Jing Wang
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| | - Xiangcong Yin
- Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
| | - Shuai-Shuai Li
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| | - Liang Wang
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China.
| |
Collapse
|
9
|
Li G, Ren J, Yao P, Duan Y, Zhang H, Wu Q, Feng J, Lau PCK, Zhu D. Deracemization of 2-Methyl-1,2,3,4-Tetrahydroquinoline Using Mutant Cyclohexylamine Oxidase Obtained by Iterative Saturation Mutagenesis. ACS Catal 2014. [DOI: 10.1021/cs401065n] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Guangyue Li
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Jie Ren
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Peiyuan Yao
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Yitao Duan
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Hailing Zhang
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Qiaqing Wu
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Jinhui Feng
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| | - Peter C. K. Lau
- National Research
Council Canada, 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada
- Departments of Chemistry and Microbiology & Immunology, McGill University, Montreal, Quebec, H3A 2B4, Canada
- FQRNT Centre in
Green Chemistry and Catalysis, Montreal, Quebec, Canada
| | - Dunming Zhu
- National
Engineering Laboratory for Industrial Enzymes and Tianjin Engineering
Center for Biocatalytic Technology, Tianjin Institute of Industrial
Biotechnology, Chinese Academy of Sciences, 32 Xi Qi Dao, Tianjin Airport Economic
Area, Tianjin 300308, People’s Republic of China
| |
Collapse
|
19
|
Banks A, Breen GF, Caine D, Carey JS, Drake C, Forth MA, Gladwin A, Guelfi S, Hayes JF, Maragni P, Morgan DO, Oxley P, Perboni A, Popkin ME, Rawlinson F, Roux G. Process Development and Scale Up of a Glycine Antagonist. Org Process Res Dev 2009. [DOI: 10.1021/op9001824] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Adam Banks
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Gary F. Breen
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Darren Caine
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - John S. Carey
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Christopher Drake
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Michael A. Forth
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Asa Gladwin
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Simone Guelfi
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Jerome F. Hayes
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Paolo Maragni
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - David O. Morgan
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Paul Oxley
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Alcide Perboni
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Matthew E. Popkin
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Fiona Rawlinson
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| | - Guillaume Roux
- Chemical Development, GlaxoSmithKline Pharmaceuticals, Old Powder Mills, Leigh, nr. Tonbridge, Kent TN11 9AN, United Kingdom, Chemical Development, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom, and Chemical Development, GlaxoSmithKline Pharmaceuticals, Via Fleming 4, 37135 Verona, Italy
| |
Collapse
|